Artificial Intelligence and the Future of Healthcare and Biotech

AI has a massive role to play in the big leaps ahead for biotech and human health from enabling us to explore biology in ways never before possible to speeding up the pace at which we discover and deliver new interventions. Hear more on what’s ahead from Anas El Turabi of McKinsey & Company; Jonathan Carlson of Microsoft Health Futures; Generate Biomedicines and Flagship Pioneering’s Mike Nally; and Rory Kelleher of NVIDIA as they join Flagship’s Armen Mkrtchyan to discuss some of the exciting recent developments in the artificial intelligence space. About Flagship Pioneering: Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple transformative human health and sustainability products. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures. The current Flagship ecosystem comprises 44 companies, including Denali Therapeutics, Foghorn Therapeutics, Generate Biomedicines, Inari, Indigo Agriculture, Moderna, Omega Therapeutics, Sana Biotechnology, Seres Therapeutics, and Tessera Therapeutics. Website: www.flagshipioneering.com Twitter: @FlagshipPioneer Linkedin:   / flagship-pioneering